Terns Pharmaceuticals (TERN) Earnings Date & Reports
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TERN is expected to report earnings to rise 8.75% to -30 cents per share on April 01
Q4'24
Est.
$-0.30
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.05
Q4'23
Est.
$-0.29
The last earnings report on November 12 showed earnings per share of -28 cents, beating the estimate of -32 cents. With 1.46M shares outstanding, the current market capitalization sits at 295.59M.